ArticleOncology letters2018

Value of α-fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma.

Ana Isabel Plano Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.